ArticleThe Journal of clinical investigation2019

Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.

M Hanief Sofi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.